- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04083989
Investigation of Psycho-Physiological Parameters in Adolescent Inpatients With Anorexia Nervosa
September 9, 2019 updated by: ARCIM Institute Academic Research in Complementary and Integrative Medicine
Adolescent Inpatients With Anorexia Nervosa: Changes in Heart Rate Variability, Body Warmth and Eating Disorder Features - a Prospective Controlled Study
A study to assess changes in mental and physical symptoms in adolescent inpatients with anorexia nervosa, a severe eating disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective controlled trial to assess changes in psycho-physiological parameters, including eating disorder features (drive for thinness, body dissatisfaction) and comorbid symptoms such as anxiety, depression and quality of life as well as heart rate variability, body warmth and BMI in adolescent inpatients with anorexia nervosa.
Parameters were assessed at admission, six weeks after admission and three months thereafter and compared to reference values of healthy controls.
Study Type
Observational
Enrollment (Actual)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Baden-Württemberg
-
Filderstadt, Baden-Württemberg, Germany, 70794
- Die Filderklinik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 16 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adolescent patients with Anorexia Nervosa who are admitted to the Filderklinik's ward for eating disorders to attend a specific inpatient treatment program based on anthroposophic medicine
Description
Inclusion Criteria:
- Age 11-18 years
- Restrictive subtype of adolescent AN
- Fulfilling the AN diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV and V)
- Admitted to the Filderklinik for inpatient treatment
Exclusion Criteria:
- Patients diagnosed with the binge-purge subtype of adolescent AN or with other eating disorders
- Healthy controls: BMI beyond the defined norm for their age group
- Healthy controls: acute or chronic disorders including psychiatric disorders, heart defects, cardiac arrhythmia, other disorders requiring medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Multimodal treatment for AN
Adolescent patients with AN attending an integrative medicine-based inpatient treatment program
|
Multimodal inpatient treatment program based on anthroposophic medicine, including individual and group psychotherapy, family therapy, art therapies and specific nursing applications such as embrocations, rhythmical massage and oil dispersion baths.
|
Healthy controls
Healthy volunteers assessed once to collect comparative data
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Drive for Thinness
Time Frame: At admission (timepoint 1, t1), six weeks after admission (t2), and three months after t2 (t3)
|
Assessed with the 7-item subscale Drive for Thinness of the self-reporting Eating Disorder Inventory-2 at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (timepoint 1, t1), six weeks after admission (t2), and three months after t2 (t3)
|
Change in Body Dissatisfaction
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Assessed with the 9-item subscale Body Dissatisfaction of the self-reporting Eating Disorder Inventory-2 at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Assessed with the 7-item subscale Anxiety of the self-reporting Hospital Anxiety and Depression Scale at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Depression
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Assessed with the 7-item subscale Depression of the self-reporting Hospital Anxiety and Depression Scale at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
SF-12 physical
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Physical health-related quality of life, assessed with the 6-item subscale Physical Health of the self-reporting Health-Related Quality of Life Questionnaire (SF-12) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
SF-12 mental
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Mental health-related quality of life, assessed with the 6-item subscale Mental Health of the self-reporting Health-Related Quality of Life Questionnaire (SF-12) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
SF-12 global
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Overall health-related quality of life, assessed with the self-reporting 12-item Health-Related Quality of Life Questionnaire (SF-12 sum-score) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Weight gain
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Change in BMI (kg/m2) based on body weight measurements taken at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Heart rate
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Heart rate (beats/min), derived from 24h ECG recordings
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Heart rate variability: SDNN
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Standard deviation of normal to normal (NN) intervals (ms), derived from 24h ECG recordings
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Body warmth
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Body surface temperature (°C) at the inner canthi of both eyes, measured with high-resolution infrared thermography at admission (t1), six weeks after admission (t2) and three months after t2 (t3)
|
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2013
Primary Completion (Actual)
October 9, 2014
Study Completion (Actual)
October 9, 2014
Study Registration Dates
First Submitted
September 5, 2019
First Submitted That Met QC Criteria
September 9, 2019
First Posted (Actual)
September 10, 2019
Study Record Updates
Last Update Posted (Actual)
September 10, 2019
Last Update Submitted That Met QC Criteria
September 9, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ANS_01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Rosemary Claire RodenChildren's Miracle NetworkEnrolling by invitationBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Linnaeus UniversityGöteborg University; Linkoeping UniversityRecruitingBulimia Nervosa | Major Depression | Anorexia Nervosa/BulimiaSweden
-
Umeå UniversityActive, not recruitingAnorexia Nervosa | Anorexia in Adolescence | Anorexia Nervosa, AtypicalSweden
-
Yeshiva UniversityYale UniversityRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa, Atypical | Bulimia; AtypicalUnited States
-
The Miriam HospitalUnknownEating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia Nervosa Restricting TypeUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Atypical Anorexia NervosaUnited States
Clinical Trials on Integrative medicine-based multimodal treatment
-
Universität Duisburg-EssenUniversity of Witten/HerdeckeCompleted
-
Akdeniz UniversityCompletedNurse's Role | Uncontrolled Hypertension | Behavior, Health | Treatment ComplianceTurkey
-
Carmel Medical CenterCompletedQuality of Life | Cancer | Nurse's RoleIsrael
-
Jaseng Medical FoundationRecruitingSciatica | Paresthesia | Radiating Pain | DysesthesiaKorea, Republic of
-
Universität Duisburg-EssenCompletedCOVID-19 | FatigueGermany
-
Duke UniversityNational Institutes of Health (NIH); National Institute on Deafness and Other...Completed
-
Bnai Zion Medical CenterRecruiting
-
University of ArizonaNot yet recruitingIntegrative Medicine
-
Jaseng Medical FoundationRecruitingFacial Paralysis, PeripheralKorea, Republic of
-
Scripps Center for Integrative MedicineUnknown